Intracranial stents are used for intracranial stenosis and brain aneurysms to open the blocked arteries. This procedure is relatively new for these conditions and long-term enhanced results for placement of these stents alone is still under investigation. However, various studies accepted the potential of placement of stents to reduce the risk of stroke in patients with symptomatic intracranial stenosis as compared to medical therapy alone. Thus, boosting the growth of the market over the forecast period.

Market Dynamics

Factors such as increasing prevalence of brain aneurysms and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are propelling demand for intracranial stents. However, high cost and stringent government regulations is negatively impacting growth of the market. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers. For instance, in January 2018, Stryker announced the positive results of WEAVE, the post market surveillance study of the company's Wingspan stent system, for the patients suffering from intracranial atherosclerotic disease (ICAD). Thus, providing more opportunities in procedural approach with significant results.

Key features of the study

• This report provides in-depth analysis of the intracranial stents market, market size (USD Bn) and compound annual growth rate (CAGR) (%) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global intracranial stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
• Key players covered as a part of this study include Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technological up-gradation, market expansion, and marketing tactics
• The global intracranial stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for intracranial stents market, research and consulting firms, new entrants, and financial analysts

 Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Self-Expanding Intracranial Stents
  • Embolization Coil Support Intracranial Stents
• By Disease Indication (Revenue, USD Bn, 2021-2033)
  • Brain Aneurysm
  • Intracranial Stenosis
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Ambulatory Surgical Centers
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Medtronic Plc
  • Balt Extrusion S.A.
  • MicroPort Scientific Corporation
  • Abbott Laboratories
  • Stryker Corporation
  • Admedes Schuessler GmbH
  • Cardiatis, S.A
  • DePuy Synthes
  • Acandis GmbH
  • Penumbra, Inc.